These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Will chronic rejection ever respond to treatment?
    Author: Häyry P, Mennander A.
    Journal: Transpl Int; 1992; 5 Suppl 1():S578-9. PubMed ID: 14621880.
    Abstract:
    In acute allograft rejection, the end-point is irreversible damage of the graft (microvascular) endothelium by inflammatory cells and antibodies, and thrombosis and necrosis of the graft. In chronic rejection a prime manifestation, common to all transplants, is persistant perivascular inflammation and concentric longitudinal allograft arteriosclerosis affecting particularly the first and second order intragraft branches of transplant arteries (Table 1). Thus, to understand the molecular mechanism of chronic rejection, we should know how the immune inflammation regulates vascular smooth muscle cell (SMC) proliferation.
    [Abstract] [Full Text] [Related] [New Search]